$4.80
+0.58 (+13.74%)
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-16.0% upside
Low Target
$3.03
Average Target
$4.03
High Target
$5.66
Current Price
$4.80
Current
$4.80
$4.80
Target
$4.03
$4.03
$3.03
$4.03 avg
$5.66
Scenario Analysis
Bear Case
$3.03
-36.9%
Low target
Base Case
$4.03
-16.0%
Avg target
Bull Case
$5.66
+17.9%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$5.30
-9.4% from high
52-Week Low
$2.69
+78.4% from low
Target vs 52W High
$4.03
-24.0% vs high
Next Earnings Report
Feb 23, 2026 · After Market Close
7d
until earnings
EPS Est: $-0.31
Earnings in 7 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |